Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imeglimin in type 2 diabetes mellitus
2011-004086-32Phase 2Completed
- Sponsor
- Poxel SA
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of imeglimin in type 2 diabetes mellitus (T2DM), sponsored by Poxel SA. Started Oct 2011; status: completed.
02
Drugs
imeglimin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-004086-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004086-32.